The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nitazoxanide Drug Market Research Report 2025
Synopsis
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The global Nitazoxanide Drug market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 226.4 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nitazoxanide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitazoxanide Drug.
Report Scope
The Nitazoxanide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitazoxanide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitazoxanide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Romark Laboratories
Chugai Pharmaceutical
Lupin
Segment by Type
Tablets
Oral Suspension
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitazoxanide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitazoxanide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The global Nitazoxanide Drug market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 226.4 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nitazoxanide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitazoxanide Drug.
Report Scope
The Nitazoxanide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitazoxanide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitazoxanide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Romark Laboratories
Chugai Pharmaceutical
Lupin
Segment by Type
Tablets
Oral Suspension
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitazoxanide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitazoxanide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nitazoxanide Drug Market Overview
1.1 Product Overview and Scope of Nitazoxanide Drug
1.2 Nitazoxanide Drug Segment by Type
1.2.1 Global Nitazoxanide Drug Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Nitazoxanide Drug Segment by Application
1.3.1 Global Nitazoxanide Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Nitazoxanide Drug Market Size Estimates and Forecasts
1.4.1 Global Nitazoxanide Drug Revenue 2019-2030
1.4.2 Global Nitazoxanide Drug Sales 2019-2030
1.4.3 Global Nitazoxanide Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nitazoxanide Drug Market Competition by Manufacturers
2.1 Global Nitazoxanide Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nitazoxanide Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nitazoxanide Drug Average Price by Manufacturers (2019-2024)
2.4 Global Nitazoxanide Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nitazoxanide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitazoxanide Drug, Product Type & Application
2.7 Nitazoxanide Drug Market Competitive Situation and Trends
2.7.1 Nitazoxanide Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitazoxanide Drug Players Market Share by Revenue
2.7.3 Global Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitazoxanide Drug Retrospective Market Scenario by Region
3.1 Global Nitazoxanide Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nitazoxanide Drug Global Nitazoxanide Drug Sales by Region: 2019-2030
3.2.1 Global Nitazoxanide Drug Sales by Region: 2019-2024
3.2.2 Global Nitazoxanide Drug Sales by Region: 2025-2030
3.3 Global Nitazoxanide Drug Global Nitazoxanide Drug Revenue by Region: 2019-2030
3.3.1 Global Nitazoxanide Drug Revenue by Region: 2019-2024
3.3.2 Global Nitazoxanide Drug Revenue by Region: 2025-2030
3.4 North America Nitazoxanide Drug Market Facts & Figures by Country
3.4.1 North America Nitazoxanide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nitazoxanide Drug Sales by Country (2019-2030)
3.4.3 North America Nitazoxanide Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nitazoxanide Drug Market Facts & Figures by Country
3.5.1 Europe Nitazoxanide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nitazoxanide Drug Sales by Country (2019-2030)
3.5.3 Europe Nitazoxanide Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitazoxanide Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Nitazoxanide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nitazoxanide Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Nitazoxanide Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nitazoxanide Drug Market Facts & Figures by Country
3.7.1 Latin America Nitazoxanide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nitazoxanide Drug Sales by Country (2019-2030)
3.7.3 Latin America Nitazoxanide Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitazoxanide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitazoxanide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nitazoxanide Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nitazoxanide Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitazoxanide Drug Sales by Type (2019-2030)
4.1.1 Global Nitazoxanide Drug Sales by Type (2019-2024)
4.1.2 Global Nitazoxanide Drug Sales by Type (2025-2030)
4.1.3 Global Nitazoxanide Drug Sales Market Share by Type (2019-2030)
4.2 Global Nitazoxanide Drug Revenue by Type (2019-2030)
4.2.1 Global Nitazoxanide Drug Revenue by Type (2019-2024)
4.2.2 Global Nitazoxanide Drug Revenue by Type (2025-2030)
4.2.3 Global Nitazoxanide Drug Revenue Market Share by Type (2019-2030)
4.3 Global Nitazoxanide Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nitazoxanide Drug Sales by Application (2019-2030)
5.1.1 Global Nitazoxanide Drug Sales by Application (2019-2024)
5.1.2 Global Nitazoxanide Drug Sales by Application (2025-2030)
5.1.3 Global Nitazoxanide Drug Sales Market Share by Application (2019-2030)
5.2 Global Nitazoxanide Drug Revenue by Application (2019-2030)
5.2.1 Global Nitazoxanide Drug Revenue by Application (2019-2024)
5.2.2 Global Nitazoxanide Drug Revenue by Application (2025-2030)
5.2.3 Global Nitazoxanide Drug Revenue Market Share by Application (2019-2030)
5.3 Global Nitazoxanide Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Romark Laboratories
6.1.1 Romark Laboratories Corporation Information
6.1.2 Romark Laboratories Description and Business Overview
6.1.3 Romark Laboratories Nitazoxanide Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Romark Laboratories Nitazoxanide Drug Product Portfolio
6.1.5 Romark Laboratories Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Corporation Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Nitazoxanide Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chugai Pharmaceutical Nitazoxanide Drug Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Corporation Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Nitazoxanide Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Nitazoxanide Drug Product Portfolio
6.3.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitazoxanide Drug Industry Chain Analysis
7.2 Nitazoxanide Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitazoxanide Drug Production Mode & Process
7.4 Nitazoxanide Drug Sales and Marketing
7.4.1 Nitazoxanide Drug Sales Channels
7.4.2 Nitazoxanide Drug Distributors
7.5 Nitazoxanide Drug Customers
8 Nitazoxanide Drug Market Dynamics
8.1 Nitazoxanide Drug Industry Trends
8.2 Nitazoxanide Drug Market Drivers
8.3 Nitazoxanide Drug Market Challenges
8.4 Nitazoxanide Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nitazoxanide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nitazoxanide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nitazoxanide Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nitazoxanide Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nitazoxanide Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nitazoxanide Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nitazoxanide Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nitazoxanide Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nitazoxanide Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nitazoxanide Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nitazoxanide Drug, Product Type & Application
Table 12. Global Key Manufacturers of Nitazoxanide Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nitazoxanide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitazoxanide Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nitazoxanide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nitazoxanide Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Nitazoxanide Drug Sales Market Share by Region (2019-2024)
Table 19. Global Nitazoxanide Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Nitazoxanide Drug Sales Market Share by Region (2025-2030)
Table 21. Global Nitazoxanide Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nitazoxanide Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Nitazoxanide Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nitazoxanide Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Nitazoxanide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nitazoxanide Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Nitazoxanide Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Nitazoxanide Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nitazoxanide Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nitazoxanide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nitazoxanide Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nitazoxanide Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nitazoxanide Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nitazoxanide Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nitazoxanide Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nitazoxanide Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nitazoxanide Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nitazoxanide Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nitazoxanide Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nitazoxanide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nitazoxanide Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nitazoxanide Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nitazoxanide Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nitazoxanide Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nitazoxanide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nitazoxanide Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nitazoxanide Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nitazoxanide Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nitazoxanide Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nitazoxanide Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Nitazoxanide Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Nitazoxanide Drug Sales Market Share by Type (2019-2024)
Table 53. Global Nitazoxanide Drug Sales Market Share by Type (2025-2030)
Table 54. Global Nitazoxanide Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nitazoxanide Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nitazoxanide Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Nitazoxanide Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Nitazoxanide Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Nitazoxanide Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Nitazoxanide Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Nitazoxanide Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Nitazoxanide Drug Sales Market Share by Application (2019-2024)
Table 63. Global Nitazoxanide Drug Sales Market Share by Application (2025-2030)
Table 64. Global Nitazoxanide Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nitazoxanide Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nitazoxanide Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Nitazoxanide Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Nitazoxanide Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Nitazoxanide Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Romark Laboratories Corporation Information
Table 71. Romark Laboratories Description and Business Overview
Table 72. Romark Laboratories Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Romark Laboratories Nitazoxanide Drug Product
Table 74. Romark Laboratories Recent Developments/Updates
Table 75. Chugai Pharmaceutical Corporation Information
Table 76. Chugai Pharmaceutical Description and Business Overview
Table 77. Chugai Pharmaceutical Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chugai Pharmaceutical Nitazoxanide Drug Product
Table 79. Chugai Pharmaceutical Recent Developments/Updates
Table 80. Lupin Corporation Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Lupin Nitazoxanide Drug Product
Table 84. Lupin Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Nitazoxanide Drug Distributors List
Table 88. Nitazoxanide Drug Customers List
Table 89. Nitazoxanide Drug Market Trends
Table 90. Nitazoxanide Drug Market Drivers
Table 91. Nitazoxanide Drug Market Challenges
Table 92. Nitazoxanide Drug Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nitazoxanide Drug
Figure 2. Global Nitazoxanide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nitazoxanide Drug Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Nitazoxanide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nitazoxanide Drug Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Other
Figure 11. Global Nitazoxanide Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Nitazoxanide Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Nitazoxanide Drug Sales (2019-2030) & (K Units)
Figure 14. Global Nitazoxanide Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Nitazoxanide Drug Report Years Considered
Figure 16. Nitazoxanide Drug Sales Share by Manufacturers in 2023
Figure 17. Global Nitazoxanide Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Nitazoxanide Drug Players: Market Share by Revenue in 2023
Figure 19. Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Nitazoxanide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Nitazoxanide Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Nitazoxanide Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Nitazoxanide Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Nitazoxanide Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Nitazoxanide Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Nitazoxanide Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Nitazoxanide Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Nitazoxanide Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Nitazoxanide Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Nitazoxanide Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Nitazoxanide Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Nitazoxanide Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Nitazoxanide Drug by Type (2019-2030)
Figure 55. Global Nitazoxanide Drug Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Nitazoxanide Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Nitazoxanide Drug by Application (2019-2030)
Figure 58. Global Nitazoxanide Drug Price (US$/Unit) by Application (2019-2030)
Figure 59. Nitazoxanide Drug Value Chain
Figure 60. Nitazoxanide Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
